Evidence map›Paper›PMID 42288798›Full record

ArticleAIDS research and therapy2026

Multilevel factors associated with virological suppression among adolescents and young people with prior non-suppression receiving intensive adherence counselling in East-Central Uganda.

David Livingstone Ejalu, Juliana Namutundu, Sean Steven Puleh, Acen Joy, Ziadah Nankinga, Stella Immaculate Akech, Joanita Nangendo, Sabrina Bakeera-Kitaka, Achilles Katamba, Anne R Katahoire and 4 more

Abstract read
In one paragraph

Article in AIDS research and therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

David Livingstone EjaluClinical Epidemiology Unit, School of Medicine, College of Health Sciences, Makerere University, P.O Box 7072, Kampala, Uganda. davidejalu@gmail.com.ORCID http://orcid.org/0000-0003-1828-6046
Juliana NamutunduSchool of Public Health, College of Health Sciences, Makerere University, Kampala, Uganda.
Sean Steven PulehClinical Epidemiology Unit, School of Medicine, College of Health Sciences, Makerere University, P.O Box 7072, Kampala, Uganda.
Acen JoyClinical Epidemiology Unit, School of Medicine, College of Health Sciences, Makerere University, P.O Box 7072, Kampala, Uganda.
Ziadah NankingaClinical Epidemiology Unit, School of Medicine, College of Health Sciences, Makerere University, P.O Box 7072, Kampala, Uganda.
Stella Immaculate AkechClinical Epidemiology Unit, School of Medicine, College of Health Sciences, Makerere University, P.O Box 7072, Kampala, Uganda.
Joanita NangendoClinical Epidemiology Unit, School of Medicine, College of Health Sciences, Makerere University, P.O Box 7072, Kampala, Uganda.
Sabrina Bakeera-KitakaClinical Epidemiology Unit, School of Medicine, College of Health Sciences, Makerere University, P.O Box 7072, Kampala, Uganda.
Achilles KatambaClinical Epidemiology Unit, School of Medicine, College of Health Sciences, Makerere University, P.O Box 7072, Kampala, Uganda.
Anne R KatahoireClinical Epidemiology Unit, School of Medicine, College of Health Sciences, Makerere University, P.O Box 7072, Kampala, Uganda.
Joan KalyangoClinical Epidemiology Unit, School of Medicine, College of Health Sciences, Makerere University, P.O Box 7072, Kampala, Uganda.
Adithya CattamanchiDepartment of Medicine, University of California, Irvine, Irvine, CA, USA.
Fred C SemitalaClinical Epidemiology Unit, School of Medicine, College of Health Sciences, Makerere University, P.O Box 7072, Kampala, Uganda.
Moses R KamyaClinical Epidemiology Unit, School of Medicine, College of Health Sciences, Makerere University, P.O Box 7072, Kampala, Uganda.

Funding

Building Implementation Science Capacity at Makerere University to Strengthen the Response to the HIV/AIDS Epidemic in UgandaD43TW010037 · FIC · MAKERERE UNIVERSITY COLLEGE OF HEALTH SCIENCES · PI KAMYA, MOSES ROBERT, SEMITALA, FRED C · 2015 to 2025
$3.3M
FIC NIH HHS D43 TW010037Fogarty International Centre, the National Institute of Mental Health, and the Office of AIDS Research of the U.S. National Institutes of Health (NIH) Award Number: D43 TW010037.
6 · The paper itself

Abstract

backgroundAdolescents and young people living with HIV continue to experience disproportionately high rates of virological non-suppression despite scale-up of enhanced adherence interventions such as Intensive Adherence Counselling (IAC). While prior research has quantified post-IAC suppression outcomes, there remains limited empirical evidence regarding the multilevel factors that shape virological response in this population. This study investigated multilevel factors associated with viral load suppression among adolescents and young people (AYP) with prior non-suppression who were enrolled in IAC in East-Central Uganda.

methodsA facility-based analytical cross-sectional study was conducted using routinely collected programmatic data from 580 AYP aged 10-24 years with documented unsuppressed viral load who were enrolled in IAC across 32 health facilities. Eligible participants had a repeat viral load measurement following completion of the adherence intervention. Multivariable analysis was performed using modified Poisson regression with robust variance estimation to determine factors independently associated with virological suppression, accounting for clustering at the facility level. Adjusted prevalence ratios (aPRs) with corresponding 95% confidence intervals were reported.

resultsThe study population had a median age of 16.4 years (interquartile range [IQR]: 12.9-21.2), with females comprising 62.8% of participants. Overall, over half of the cohort achieved virological suppression following the intervention. Engagement in peer-led support was associated with a higher likelihood of suppression (aPR = 1.71, 95% CI: 1.36-2.15), as was prior disclosure of HIV status (aPR = 1.43, 95% CI: 1.02-2.11). Conversely, participants enrolled in differentiated antiretroviral therapy (ART) delivery models based on community drug distribution prior to IAC had lower suppression compared to those managed through facility-based individualized care (aPR = 0.51, 95% CI: 0.35-0.74).

conclusionVirological outcomes among AYP receiving enhanced adherence support are shaped by a combination of individual and service delivery factors. Interventions that strengthen peer engagement and facilitate safe disclosure, alongside careful alignment of differentiated service delivery models with adherence needs, may improve treatment outcomes in this high-risk population.

Indexed as

Anti-HIV AgentsCounselingHIV InfectionsMedication AdherenceViral LoadAdherence InterventionsAdolescentChildCross-Sectional StudiesFemaleHumansMaleUgandaYoung AdultAnti-HIV AgentsAdherence supportDifferentiated service deliveryVirological suppression

Identifiers

PMID42288798
PMCPMC13520402

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.